In the last 20 years, corporate funding in the fields of information technology and biotechnology has grown faster than support from any other source, and there is growing concern over possible corporate interference and industrial pressures that could inappropriately influence the direction, interpretation, and outcome of research. This past summer, several organizations took measures to examine and address this situation.